Hence, future studies focusing on further understanding the molecular mechanisms through which obesity augments asthma severity and randomized clinical trials to evaluate the efficacy of metformin and GLP-1R agonists in the treatment of obesity-associated asthma are needed. The gene discussed is GLP1R; the disease is asthma.